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Figure S1: EI-mass spectrum of methyl (E)-11-methyloctadec-12-enoate. After separation of the phases, the organic phase was dried with MgSO 4 , filtered and the solvent was evaporated in a gentle stream of nitrogen. The residue was redissolved in DCM and analyzed by GC/MS [1, 3, 4] .
Gene cloning: Genomic DNA was isolated from liquid cultures of P. inhibens DSM17395 and D. shibae DFL-12 in half strength MB medium grown for 7 days using a standard protocol based on phenol/chloroform/isoamyl alcohol extraction [5] .
Using these templates, the target AHL synthase genes pgaI 2 , luxI 1 and luxI 2 (for accession numbers, see Table S1 ) were amplified by PCR using Phusion DNA polymerase (New England Biolabs, Ipswich, MA, USA) and the primers without homology arms listed in Table 5 (PCR conditions: initial denaturation 95 °C for 5 min;   30 cycles 95 °C for 15 s, annealing 68 °C for 30 s, 72 °C for 30 s; final elongation 72 °C for 5 min). The obtained fragments were further elongated in a second PCR S6 reaction using the corresponding primers harboring homology arms (Table S2 ) with the reaction conditions described above. These fragments were added to linearized yeast-E. coli shuttle vector pYE-express [6] (HindIII and EcoRI digested) and used for homologous recombination in yeast by the LiOAc/SS DNA/PEG protocol [7] .
Transformed yeast colonies were grown on SM-URA medium to isolate the product plasmids by Plasmid Miniprep II kit (Zymo Research, Irvine, USA). The obtained plasmid mixtures were shuttled to E. coli BL21(DE3) cells by electroporation. The transformed cells were grown on selective LB agar medium (10 g/L tryptone, 5 g/L yeast extract, 5 g/L NaCl, 18 g/L agar, pH 7.2) supplied with kanamycin (50 g/mL) to pick single colonies, which were grown in liquid LB medium (50 g/mL kanamycin) at 37 °C. Isolated plasmids were checked for correct insertion of the target gene by analytical digest and sequencing of the positive samples. 
S10 (Z)-7-Tetradecenoic acid
To a solution of 7-tetradecynoic acid (0.22 g, 0.98 mmol) and methanol (5 mL) Lindlar's catalyst (0.02 g) was added. The mixture was stirred for 20 minutes at room temperature under a hydrogen atmosphere. The catalyst was removed by filtration through a short pad of silica and the solvent was evaporated. The product was obtained as colorless oil without the need of further purification (205 mg, 0.90 mmol, 92%) [11] . All analytical data were in agreement with those previously reported [4] .
S-Acyl-N-pantothenoyl acetonide derivatives (9)
To a stirred solution of an acid in dry DCM, p-dimethylaminopyridine (DMAP) and 8
(EDC·HCl) was added at 0 °C, the solution was stirred for 5 minutes at 0 °C and overnight at room temperature [12] . 1N HCl was added to the reaction mixture followed by extraction with DCM three times. The combined organic phases were washed with sat. NaHCO 3 sol. and brine, dried with MgSO 4 , filtered and concentrated to give an oil.
(R)-S-Butanoyl-N-pantothenoylcysteamine acetonide
Colorless oil (435 mg, 1.12 mmol, 99%) R f = 0. 
(R)-S-((Z)-7-Tetradecenoyl)-N-pantothenoylcysteamine acetonide
Colorless oil (251 mg, 0.48 mmol, 55%) R f = 0. 
(R)-S-((Z)-9-Octadecenoyl)-N-pantothenoylcysteamine acetonide
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S17 (R)-S-Acyl-N-pantothenoylcysteamines (10-13)
The thioesters 9 were dissolved in AcOH/H 2 O 2:1 (2 mL) and stirred for 5 h at room temperature. The solvent was evaporated in vacuo and the crude product was used for incubation experiments without further purification [13] .
(R)-S-Butanoyl-N-pantothenoylcysteamine (10a)
Crude product (18.9 mg, 0.05 mmol, 99%); 
(R)-S-Octanoyl-N-pantothenoylcysteamine (10c)
Crude product (7.9 mg, 0.01 mmol, 99%); 
(R)-S-((Z)-7-Tetradecenoyl)-N-pantothenoylcysteamine (11a)
Crude product (15.6 mg, 0.02 mmol, 99%); 
